![]() |
市场调查报告书
商品编码
1446223
全球医药级卡波姆市场2024-2028Global Pharmaceutical Grade Carbomers Market 2024-2028 |
预计2023-2028年医药级卡波姆市场将成长1.1307亿美元,预测期内复合年增长率为6.39%。
该报告包括对医药级卡波姆市场的总体分析、市场规模和预测、趋势、成长驱动因素、挑战以及涵盖约 25 家供应商的供应商分析。
它提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。该市场的推动因素包括对局部给药系统的需求迅速增长、全球老年人口的增加以及个人护理和化妆品中越来越多地加入药用级卡波姆。
市场范围 | |
---|---|
基准年 | 2024年 |
结束年份 | 2028年 |
预测期 | 2024-2028 |
成长动力 | 加速度 |
2024年与前一年同期比较 | 5.48% |
复合年增长率 | 6.39% |
增量 | 11307万美元 |
该研究指出,对永续和环境友善製造方法的日益关注是推动未来几年医药级卡波姆市场成长的关键原因之一。此外,对使用医药级卡波姆的生物黏附药物传输系统的需求不断增长以及水凝胶的日益采用也将带来巨大的市场需求。
The pharmaceutical grade carbomers market is forecasted to grow by USD 113.07 mn during 2023-2028, accelerating at a CAGR of 6.39% during the forecast period. The report on the pharmaceutical grade carbomers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by surge in demand for topical drug delivery systems, increasing global geriatric population, and increasing incorporation of pharmaceutical grade carbomers in personal care and cosmetic products.
Technavio's pharmaceutical grade carbomers market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 5.48% |
CAGR | 6.39% |
Incremental Value | $113.07mn |
By Application
By Type
By Geographical Landscape
This study identifies the increasing focus on sustainable and eco-friendly manufacturing practices as one of the prime reasons driving the pharmaceutical grade carbomers market growth during the next few years. Also, rising need for bioadhesive drug delivery systems using pharmaceutical grade carbomers and growing adoption of hydrogels will lead to sizable demand in the market.
The report on the pharmaceutical grade carbomers market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical grade carbomers market vendors that include 3V Sigma SpA, Anhui Newman Fine Chemicals Co. Ltd., Arihant Innochem Pvt. Ltd., Ashahi Chemical Industries Pvt. Ltd., Ashland Inc., Azelis SA, Berkshire Hathaway Inc., Corel Pharma Chem, East India Chemicals International, Evonik Industries AG, Golden Falcon General Trading LLC, Guangzhou Tinci Advanced Materials Co. Ltd., HENAN JINHE INDUSTRY CO. LTD., IMCD NV, JENE CHEMICALS, Libraw Pharma Excipients Pvt. Ltd., Maruti Chemicals, Merck KGaA, Muby Chemicals, Pioma Chemicals, Shreeji Pharma International, Sumitomo Seika Chemicals Co. Ltd., The SNF Group, Unilong Industry Co. Ltd, and Vizag Chemical International. Also, the pharmaceutical grade carbomers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: